Lamia Y. Haque

Gastroenterology | Addiction Medicine | Transplant Surgery

40 Temple St
Suite 3a
New Haven, CT 06510

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Hepatology clinician readiness to provide addiction treatment in hepatology clinics: A mixed-methods formative evaluation.

Hepatology clinician readiness to provide addiction treatment in hepatology clinics: A mixed-methods formative evaluation.

Journal: Hepatology communications

Published: March 15, 2025

Reducing alcohol-associated liver disease burden in the general population.

Reducing alcohol-associated liver disease burden in the general population.

Journal: The lancet. Gastroenterology & hepatology

Published: March 10, 2025

Concomitant treatment of alcohol associated liver disease and alcohol use disorder in the nontransplant setting: A scoping review.

Concomitant treatment of alcohol associated liver disease and alcohol use disorder in the nontransplant setting: A scoping review.

Journal: Alcohol, clinical & experimental research

Published: January 25, 2025

Epidemiology and Health Care Burden of Alcohol Use Disorder.

Epidemiology and Health Care Burden of Alcohol Use Disorder.

Journal: Clinics in liver disease

Published: October 03, 2024

Medications for Weight Loss and MASLD: A National Survey of Hepatology and Gastroenterology Provider Practices, Attitudes, and Knowledge Before Resmetirom.

Medications for Weight Loss and MASLD: A National Survey of Hepatology and Gastroenterology Provider Practices, Attitudes, and Knowledge Before Resmetirom.

Journal: Journal of clinical gastroenterology

Published: July 17, 2024

Opportunities for Alcohol-Related Care in the COVID-19 Pandemic and Beyond.

Opportunities for Alcohol-Related Care in the COVID-19 Pandemic and Beyond.

Journal: Journal of general internal medicine

Published: April 26, 2024

Using Phosphatidylethanol as an Adjunct to Self-Reported Alcohol Use Improves Identification of Liver Fibrosis Risk.

Using Phosphatidylethanol as an Adjunct to Self-Reported Alcohol Use Improves Identification of Liver Fibrosis Risk.

Journal: The American journal of gastroenterology

Published: April 14, 2024

Integrated and collaborative care across the spectrum of alcohol-associated liver disease and alcohol use disorder.

Integrated and collaborative care across the spectrum of alcohol-associated liver disease and alcohol use disorder.

Journal: Hepatology (Baltimore, Md.)

Published: April 06, 2024

A Validated Algorithm to Identify Hepatic Decompensation in the Veterans Health Administration Electronic Health Record System.

A Validated Algorithm to Identify Hepatic Decompensation in the Veterans Health Administration Electronic Health Record System.

Journal: Pharmacoepidemiology and drug safety

Published: January 29, 2024

Management of alcohol-associated liver disease and alcohol use disorder in liver transplant candidates and recipients: Challenges and opportunities.

Management of alcohol-associated liver disease and alcohol use disorder in liver transplant candidates and recipients: Challenges and opportunities.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: December 14, 2023

Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action.

Treatment of alcohol use disorder in patients with alcohol-associated liver disease: Innovative approaches and a call to action.

Journal: Addiction science & clinical practice

Published: August 01, 2023

Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus Treatment.

Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus Treatment.

Journal: JAMA network open

Published: December 14, 2022

Showing 1-12 of 25

Last Updated: 06/30/2026